NEW ZEALAND GAZETTE

No. 15

Health

Medicines Act 1981

Classification of Medicines

Pursuant to section 106 (1) of the Medicines Act 1981,
I, Don Matheson, Deputy Director-General, Public Health,
acting under delegated authority, hereby declare the
following:

1. The medicines listed in Schedule 1 to this notice are
   classified as prescription medicines.

2. The medicines listed in Schedule 2 to this notice are
   classified as restricted medicines.

3. The medicines listed in Schedule 3 to this notice are
   classified as pharmacy-only medicines.

Every reference to a medicine in this notice applies whether
the medicine is synthetic in origin or is from biological or
mineral sources.

Unless specific reference is made otherwise, every reference
applies also to medicines that are:

(a) preparations and admixtures containing any
proportion of any substance listed in the notice.

(b) salts and esters of any substance listed in the notice.

(c) preparations or extracts of biological materials listed
in the notice.

(d) salts or oxides of elements listed in the notice.

Unless specific reference is made otherwise, every reference
to a medicine applies:

(i) if the medicine is an injection or eye preparation, to
any concentration of that medicine; and

(ii) if the medicine is not an injection or eye preparation,
only if the concentration of the medicine is greater
than 10 milligrams per litre or per kilogram.

Where any reference is modified by a statement of the
strength of the medicine, the strength is calculated using
the free acid, base, alcohol or element unless specifically
stated otherwise.

Schedule 1

Prescription Medicines

Acepromazine
Adalimumab
Alefacept
Adenosine; for injection
Amethocaine; for internal use; for external use in medicines
containing more than 10%; for ophthalmic use except
when used in practice by a registered optometrist
Amylocaine
Aprepitant
Aristolochic acid; at all strengths
Atazanavir
Atomoxetine
Atropa belladonna; except when specified elsewhere in the
Schedule; except in medicines containing 300 micrograms
or less of total solanaceous alkaloids per litre or per
kilogram
Atropine; except when specified elsewhere in the Schedule;
except when used as an antidote in a device designed
for self-injection; except in medicines containing 300
micrograms or less per litre or per kilogram
Atropine methonitrate
Benorylate
Benzocaine; for internal use; for external use in medicines
containing more than 10%

Benzydamine; for internal use
Bexarotene
Butacaine
Butyl aminobenzoate; except in medicines for dermal use
containing 2% or less
Carbetocin
Cinchocaine; for ophthalmic use; for external use in
medicines containing more than 0.5%
Clindamycin
Colestyramine
Darbepoetin
Datura spp; except for oral use when specified elsewhere
in the Schedule; except in datura stramonium or datura
tatula for smoking or burning
Dextrorphan
Dicyclomine
Digoxin-specific antibody fragment
Diperodon
Drotrecogin
Duboisia leichhardtii; except when specified elsewhere in
the Schedule
Duboisia myoporides; except when specified elsewhere in
the Schedule
Ephedra
Epoetins
Etidocaine
Ezetimibe

Fluorides; for internal use except in parenteral nutrition
replacement preparations or in medicines containing
2.2 milligrams or less per dose form of sodium fluoride;
for external use in medicines other than pastes, gels or
powders for cleaning the teeth containing more than
2.5% except when used in practice by a registered dental
therapist; except in medicines containing 15 milligrams
or less per litre or per kilogram

Folic acid; for injection
Folinic acid; for injection
Gefitinib
Glatiramer acetate
Glyceryl trinitrate; for injection; for transdermal use; except
in medicines containing 100 micrograms or less per litre
or per kilogram
Guaiphenesin; except for oral use in medicines containing
2% or less or 200 milligrams or less

Haemophilus influenzae vaccine; except in oral vaccines for
the prophylaxis of bacterial complications of colds
Homatropine
Human protein C
Hyaluronic acid; for injection except in intraocular
viscoelastic products

Hyoscine; except when specified elsewhere in the Schedule;
except in medicines containing 300 micrograms or less
per litre or per kilogram
Hyoscine butylbromide; except when specified elsewhere in
the Schedule
Hyoscyamine; except when specified elsewhere in the
Schedule; except in medicines containing 300 micrograms
or less per litre or per kilogram

Hyoscyamus niger; except when specified elsewhere in the
Schedule; except in medicines containing 300 micrograms
or less of total solanaceous alkaloids per litre or per
kilogram

Hypromellose; for injection except in intraocular viscoelastic
products
Ibritumomab tiuxetan